Skip to content
Maui Sky – Lifestyle
Author:
Menarini Industrie Farmaceutiche Riunite
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
November 4, 2026
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
October 22, 2026
THIRTY YEARS TO REMEMBER: THE FAIR PLAY MENARINI AWARD SHINES AT THE TEATRO DEL MAGGIO MUSICALE FIORENTINO
July 3, 2026
FAIR PLAY MENARINI INTERNATIONAL AWARD: THE 30TH EDITION KICKS OFF
July 1, 2026
Fair Play Menarini International Award
June 23, 2026
FROM DUPLANTIS TO PALTRINIERI, FAIR PLAY MENARINI KICKS OFF ITS 30TH EDITION
June 4, 2026